Skip to content
Screener

Progyny PGNY Shares (Diluted)

Shares (Diluted) at other companies

CVS Health logo
CVS HealthCVS
1.3B+1.3%
UnitedHealth Group logo
UnitedHealth GroupUNH
910M-0.9%
Organon logo
OrganonOGN
262.9M+0.7%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
54.5M+424%
Natera, Inc. logo
Natera, Inc.NTRA
143.3M+5.1%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
112.5M-2.9%

Other financials

Income statement

See full
Revenue$350.5M+5.3%
Gross profit$89.3M+13.1%
Operating income$40.0M+64.2%
Net income$28.1M+63.9%
EPS (diluted)$0.34+78.9%

Balance sheet

See full
Cash & equivalents$152.6M+15.2%
Total debt$27.0M-5.8%
Total equity$453.3M-12.0%
Total assets$715.8M-5.9%

Cash flow

See full
Operating cash flow$50.4M-9.2%
CapEx$6.2M+18.0%
Free cash flow$44.2M-12.0%

Valuation

See full
Market cap$2.37B+17.5%
Enterprise value$2.24B+17.3%
P/E30.1×-7.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin24.6%+2.2pp
Operating margin8.6%+2.4pp
Net margin6%+1.7pp
FCF margin13.6%-1.7pp

Returns & leverage

See full
Return on equity16.2%+5.3pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.6×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Progyny’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 9:00 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001551306-26-000140
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Provision for income taxes13,0859,96525,73621,443
Net income$28,052$17,112$52,284$32,171
Net income per share:
Basic$0.36$0.20$0.66$0.38
Diluted$0.34$0.19$0.63$0.36
Weighted-average shares used in computing net income per share:
Basic78,165,23585,766,25479,528,56985,644,091
Diluted82,141,42889,638,67783,476,44689,507,906

Item 1. Financial Statements (Unaudited)

FAQ

What is Progyny's shares (diluted)?
Progyny (PGNY) reported shares (diluted) of 82.1M in Q2 2026.
How has Progyny's shares (diluted) changed year-over-year?
Progyny's shares (diluted) decreased by 8.4% year-over-year, from 89.6M to 82.1M.
What is the long-term trend for Progyny's shares (diluted)?
Over 4 years (2021 to 2025), Progyny's shares (diluted) has grown at a -2.7% compound annual growth rate (CAGR), from 400.6M to 358.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Progyny's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude